Results 161 to 170 of about 49,584,610 (301)

Trends in pneumothorax mortality in England (2004-2023): a population-based observational study. [PDF]

Lancet Reg Health Eur
Zhong X, Morris EJA, Goldacre R, Hallifax RJ.   +3 more
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Laser treatment of oral vascular anomalies. A retrospective observational study. [PDF]

Med Oral Patol Oral Cir Bucal
Monteiro L, Fazendeiro C, Ferreira S, Delgado L, Pacheco JJ, Salazar F.   +5 more
europepmc   +1 more source

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Lancet Neurology, 2013
M. Titulaer, Lindsey Mccracken, I. Gabilondo, T. Armangué, C. Glaser, T. Iizuka, Lawrence S. Honig, S. Benseler, I. Kawachi, E. Martínez-Hernandez, E. Aguilar, N. Gresa-arribas, Nicole Ryan-Florance, A. Torrents, A. Saiz, M. Rosenfeld, R. Balice-Gordon, F. Graus, J. Dalmau   +18 more
semanticscholar   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

Potential pitfalls in observational study designs

Southwest Respiratory and Critical Care Chronicles, 2016
Phillip Watkins
doaj  

Biochemical osteomalacia during pregnancy or lactation: an observational study in Sweden. [PDF]

BMC Pregnancy Childbirth
Torstensson T, Kristiansson P, Kalliokoski P.   +2 more
europepmc   +1 more source

Crucial parameters for precise copy number variation detection in formalin‐fixed paraffin‐embedded solid cancer samples

Molecular Oncology, EarlyView.
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris, Vasiliki Siozopoulou, Léon C van Kempen, Anne Sieben, Ella Roelant, Stig Hellemans, Elyne Backx, Laure Sorber, Koen De Winne, Senada Koljenović, Karen Zwaenepoel   +10 more
wiley   +1 more source

The Thromboembolism Heparinization and AntithrombiN Observational Study (THANOS-1). [PDF]

Res Pract Thromb Haemost
Prucnal CK, Wang G, Huang W, Horick N, Mize R, Dhar I, Brown T, Flomenbaum S, Chang KE, Matthews TM, Peters GA, Birrenkott DA, Stannek K, Lee EES, Uljon S, Kabrhel C.   +15 more
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source